Advertisement
Advertisement
HAE
Haemonetics Corporation
87.84
USDSponsored
+2.82
+3.32%
Aug 07, 15:59 UTC -4
Closed
After-Market
84.70
-3.14
-3.57%
HAE Earnings Reports
Positive Surprise Ratio
HAE beat 36 of 42 last estimates.
86%
Next Report
Date of Next Report
Nov 04, 2026
Estimate for Q2 27 (Revenue/ EPS)
$346.01M
/$1.28
Implied change from Q1 27 (Revenue/ EPS)
+1.95%
/+13.27%
Implied change from Q2 26 (Revenue/ EPS)
+5.71%
/+0.79%
Haemonetics Corporation earnings per share and revenue
On Aug 06, 2026, HAE reported earnings of 1.13 USD per share (EPS) for Q1 27, beating the estimate of 1.08 USD, resulting in a 4.82% surprise. Revenue reached 339.38 million, compared to an expected 331.17 million, with a 2.48% difference. The market reacted with a +1.70% price change (close before vs. close after earnings).
Looking ahead to Q2 27, 8 analysts forecast an EPS of 1.28 USD, with revenue projected to reach 346.01 million USD, implying an increase of 13.27% EPS, and increase of 1.95% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lantheus Holdings, Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.31
Actual
$1.55
Surprise
+17.50%
ICU Medical Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.95
Actual
$2.37
Surprise
+21.43%
ResMed Inc.
Report Date
Aug 06, 2026 For Q4 26
Estimate
$2.91
Actual
$2.95
Surprise
+1.09%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.02
Surprise
+54.65%
BioLife Solutions Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.03
Actual
$0.04
Surprise
+17.65%
Trulieve Cannabis Corp.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$0.06
Actual
$0.11
Surprise
+72.14%
Canopy Growth Corporation Common Shares
Report Date
Aug 07, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.02
Surprise
+75.74%
Apyx Medical Corporation Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+16.27%
United-Guardian, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
-Actual
$0.16
Surprise
-
Cytosorbents Corp.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
FAQ
What were Haemonetics Corporation's earnings and revenue for the latest quarter Q1 2027?
For Q1 2027, Haemonetics Corporation reported EPS of $1.13, beating estimates by 4.82%, and revenue of $339.38M, 2.48% above expectations.
How did the market react to Haemonetics Corporation's Q1 2027 earnings?
The stock price moved up 1.7%, changed from $83.60 before the earnings release to $85.02 the day after.
When is Haemonetics Corporation expected to report next?
The next earning report is scheduled for Nov 04, 2026.
What are the forecasts for Haemonetics Corporation's next earnings report?
Based on 8
analysts, Haemonetics Corporation is expected to report EPS of $1.28 and revenue of $346.01M for Q2 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement